Stephen Salloway
Impact in
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research
- Physiology top 0.01%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 312
- Physiology 221
- Alzheimer's disease research and treatments 221
- Co-authors
- Jeffrey L. Cummings (34 shared papers)Philip Scheltens (5 shared papers)Kaj Blennow (11 shared papers)Bart De Strooper (3 shared papers)Giovanni Battista Frisoni (6 shared papers)Paul F. Malloy (29 shared papers)Monique M.B. Breteler (1 shared paper)Wiesje M. van der Flier (2 shared papers)
- Journals
- Alzheimer s & Dementia (117 papers)Neurology (46 papers)Scientific Reports (25 papers)The Journal of Prevention of Alzheimer s Disease (24 papers)Nature Communications (19 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stephen Salloway
500 papers receiving 55k citations
Stephen Salloway's Hit Papers
Peers
Comparison fields: 5 of 199
- Psychiatry and Mental health 27.6k
- Physiology 21.8k
- Neurology 3.1k
- Neurology 4k
- Cognitive Neuroscience 3.1k
Countries citing papers authored by Stephen Salloway
This map shows the geographic impact of Stephen Salloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Salloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Salloway more than expected).
Fields of papers citing papers by Stephen Salloway
This network shows the impact of papers produced by Stephen Salloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Salloway. The network helps show where Stephen Salloway may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Salloway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 524 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria Hit paper breakdown → | 2007 | 3551 |
| 2 | Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease Hit paper breakdown → | 2012 | 3109 |
| 3 | Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Hit paper breakdown → | 2014 | 2719 |
| 4 | Alzheimer's disease Hit paper breakdown → | 2016 | 2679 |
| 5 | The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Hit paper breakdown → | 2016 | 2505 |
| 6 | Donanemab in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2023 | 1799 |
| 7 | Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease Hit paper breakdown → | 2014 | 1630 |
| 8 | Revising the definition of Alzheimer's disease: a new lexicon Hit paper breakdown → | 2010 | 1559 |
| 9 | Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria Hit paper breakdown → | 2016 | 1526 |
| 10 | Donanemab in Early Alzheimer’s Disease Hit paper breakdown → | 2021 | 1281 |
| 11 | Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Hit paper breakdown → | 2016 | 947 |
| 12 | Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group Hit paper breakdown → | 2021 | 758 |
| 13 | Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease Hit paper breakdown → | 2019 | 726 |
| 14 | Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression Hit paper breakdown → | 2008 | 722 |
| 15 | Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience Hit paper breakdown → | 2008 | 654 |
| 16 | A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease Hit paper breakdown → | 2009 | 646 |
| 17 | Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder Hit paper breakdown → | 2006 | 622 |
| 18 | Lecanemab: Appropriate Use Recommendations Hit paper breakdown → | 2023 | 586 |
| 19 | A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease Hit paper breakdown → | 2020 | 515 |
| 20 | Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease Hit paper breakdown → | 2021 | 472 |
About Stephen Salloway
Stephen Salloway is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Cognitive Neuroscience and Clinical Psychology, having authored 524 papers that have together received 56.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (312 papers), Alzheimer's disease research and treatments (221 papers), Functional Brain Connectivity Studies (27 papers), Neurological disorders and treatments (19 papers), Advanced Neuroimaging Techniques and Applications (8 papers), Obsessive-Compulsive Spectrum Disorders (8 papers), Cerebrovascular and genetic disorders (8 papers) and Neural and Behavioral Psychology Studies (7 papers). The work is most often cited by research in Psychiatry and Mental health (27.6k citations), Physiology (21.8k citations), Neurology (3.1k citations), Neurology (4k citations) and Cognitive Neuroscience (3.1k citations). Stephen Salloway has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jeffrey L. Cummings, Philip Scheltens, Kaj Blennow, Bart De Strooper, Giovanni Battista Frisoni, Paul F. Malloy, Monique M.B. Breteler, Wiesje M. van der Flier, Howard Feldman and Bruno Dubois. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Scientific Reports, The Journal of Prevention of Alzheimer s Disease and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.